These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8156390)

  • 1. Dopamine receptor density, sensitivity and mRNA levels are altered following self-administration of cocaine in the rat.
    Laurier LG; Corrigall WA; George SR
    Brain Res; 1994 Jan; 634(1):31-40. PubMed ID: 8156390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
    Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
    Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse.
    Ng GY; George SR
    Eur J Pharmacol; 1994 Nov; 269(3):365-74. PubMed ID: 7895775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-hydroxybutyrate and cocaine administration increases mRNA expression of dopamine D1 and D2 receptors in rat brain.
    Schmidt-Mutter C; Muller C; Zwiller J; Gobaille S; Maitre M
    Neuropsychopharmacology; 1999 Nov; 21(5):662-9. PubMed ID: 10516962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine.
    Briand LA; Flagel SB; Garcia-Fuster MJ; Watson SJ; Akil H; Sarter M; Robinson TE
    Neuropsychopharmacology; 2008 Nov; 33(12):2969-80. PubMed ID: 18305460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active versus passive cocaine administration: differences in the neuroadaptive changes in the brain dopaminergic system.
    Stefański R; Ziółkowska B; Kuśmider M; Mierzejewski P; Wyszogrodzka E; Kołomańska P; Dziedzicka-Wasylewska M; Przewłocki R; Kostowski W
    Brain Res; 2007 Jul; 1157():1-10. PubMed ID: 17544385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of D1- and D2-like compounds on cocaine self-administration in Lewis and Fischer 344 inbred rats.
    Haile CN; Kosten TA
    J Pharmacol Exp Ther; 2001 Nov; 299(2):509-18. PubMed ID: 11602661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide.
    Landa L; Jurajda M; Sulcova A
    Neuro Endocrinol Lett; 2012; 33(4):446-52. PubMed ID: 22936253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of prefrontal cortex D1-like and D2-like receptors in cocaine-seeking behavior in rats.
    Sun W; Rebec GV
    Psychopharmacology (Berl); 2005 Jan; 177(3):315-23. PubMed ID: 15309375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
    Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE
    Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK; Platt DM; Yao WD; Spealman RD
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific reductions of striatal prodynorphin and D1 dopamine receptor messenger RNAs during cocaine abstinence.
    Svensson P; Hurd YL
    Brain Res Mol Brain Res; 1998 May; 56(1-2):162-8. PubMed ID: 9602109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of in utero cocaine exposure on the expression of mRNAS encoding the dopamine transporter and the D1, D2 and D5 dopamine receptor subtypes in fetal rhesus monkey.
    Choi WS; Rønnekleiv OK
    Brain Res Dev Brain Res; 1996 Oct; 96(1-2):249-60. PubMed ID: 8922687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY; Martin-Iverson MT
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute binge pattern cocaine administration induces region-specific effects in D1-r- and D2-r-expressing cells in eGFP transgenic mice.
    Lawhorn C; Edusei E; Zhou Y; Ho A; Kreek MJ
    Neuroscience; 2013 Dec; 253():123-31. PubMed ID: 24001687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain.
    Kleven MS; Perry BD; Woolverton WL; Seiden LS
    Brain Res; 1990 Nov; 532(1-2):265-70. PubMed ID: 2149299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats.
    Neisewander JL; Lucki I; McGonigle P
    Synapse; 1994 Jan; 16(1):1-10. PubMed ID: 8134896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats.
    McDougall SA; Rudberg KN; Veliz A; Dhargalkar JM; Garcia AS; Romero LC; Gonzalez AE; Mohd-Yusof A; Crawford CA
    Behav Brain Res; 2017 May; 326():226-236. PubMed ID: 28284952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
    Morissette M; Goulet M; Calon F; Falardeau P; Blanchet PJ; Bédard PJ; Di Paolo T
    Mol Pharmacol; 1996 Nov; 50(5):1073-9. PubMed ID: 8913337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.